ARMATA PHARMACEUTICALS, INC. (ARMP) Operating cash flow 2016–2025
ARMATA PHARMACEUTICALS, INC. (ARMP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.8MFY2025 · since FY2016: -$10.6M → -$25.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.8M | +31.4% |
| FY2024 | -$37.6M | +20.8% |
| FY2023 | -$47.4M | -46.0% |
| FY2022 | -$32.5M | -37.8% |
| FY2021 | -$23.6M | -29.0% |
| FY2020 | -$18.3M | -17.3% |
| FY2019 | -$15.6M | -46.6% |
| FY2018 | -$10.6M | -15.6% |
| FY2017 | -$9.2M | +13.3% |
| FY2016 | -$10.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARMP financial trends
ARMP RevenueARMP Net incomeARMP Net marginARMP Gross profitARMP Gross marginARMP Operating incomeARMP Operating marginARMP Free cash flowARMP Capital expendituresARMP Return on equityARMP Stock buybacksARMP Dividends paidARMP Total assetsARMP Total liabilitiesARMP Shareholders’ equityARMP overview →